NCT04546399 2025-09-10A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Phase 2 Recruiting461 enrolled